NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1003128810 MD
Verify on CMS → Anteneh Tesfaye, MD
Hematology & Oncology Physician in Washington, District of Columbia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
366
Medicare Part D claims · 72 beneficiaries · Hematology & Oncology Physician avg: 847
Industry payments
$4.8K
25 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Anteneh Tesfaye, MD filed 366 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Washington, District of Columbia.
- 366
- Part D claims, 2023
- $4.8K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Anteneh Tesfaye, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
366 Top 43% higher than 57% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
◑
Board-eligible specialty (heuristic, not verified)
Anteneh Tesfaye, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Anteneh Tesfaye, MD?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
366 57% vs specialty avg
Specialty distribution in District of Columbia
How Hematology & Oncology Physician compares to other specialties among District of Columbia providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Anteneh Tesfaye, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 110 IRVING ST NW STE C2151, Washington, DC, 20010, with a listed phone of (202) 877-6998. NPI 1003128810 was issued on 07/09/2010.
Medicare Part D records for calendar year 2023 show 366 prescription claims written by this provider, covering 72 Medicare beneficiaries and totaling roughly $921K in drug spend, with an opioid prescribing rate of 24.9%.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1003128810 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/09/2010 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Anteneh Tesfaye, MD. Source: openpaymentsdata.cms.gov.
Total received
$4.8K
Largest payer
Exelixis Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
366
Total Claims
$921K
Total Drug Cost
72
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 478
- Total Day Supply
- 13,111
- Generic Drug Cost
- $188K
- Opioid Claims
- 91 (24.9% rate)
Patient Demographics
- Average Patient Age
- 70.5 years
- Avg HCC Risk Score
- 3.18
- Gender Split
- 64% female / 36% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Anteneh Tesfaye, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Oxycodone Hcl
Oxycodone Hcl
50 claims
- Lenvima
Lenvima
24 claims
- Levothyroxine Sodium 15
Levothyroxine Sodium
15 claims
- Morphine Sulfate Er 14
Morphine Sulfate Er
14 claims
- Prochlorperazine M… 14
Prochlorperazine Maleate
14 claims
- Oxycodone-Acetamin… 13
Oxycodone-Acetaminophen
13 claims
- Ondansetron Hcl 12
Ondansetron Hcl
12 claims
- Ondansetron Odt 12
Ondansetron Odt
12 claims
| Drug | Claims |
|---|---|
| Oxycodone Hcl | 50 |
| Lenvima Lenvatinib Mesylate | 24 |
| Levothyroxine Sodium | 15 |
| Morphine Sulfate Er Morphine Sulfate | 14 |
| Prochlorperazine Maleate | 14 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 13 |
| Ondansetron Hcl | 12 |
| Ondansetron Odt Ondansetron | 12 |
| Everolimus | 11 |
| Gabapentin | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Hematology & Oncology Physician in DC →
All providers in District of Columbia →
Compare specialties →
Hematology & Oncology Physician Overview
How Anteneh Tesfaye, MD fits within the Hematology & Oncology Physician landscape nationally.
11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Anteneh Tesfaye, MD's 366 claims are below the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in District of Columbia
Other clinicians with the same primary specialty enrolled in District of Columbia, drawn from the same CMS NPPES roster as Tesfaye.
Dr. Anita Aggarwal
DO
Washington, DC
Dr. Pedro Alcedo Andrade
MD
Washington, DC
Dr. Anthony Arcenas
M.D.
Washington, DC
Dr. Puja Arora
M.D.
Washington, DC
Ekatherine Asatiani
Washington, DC
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the District of Columbia medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore District of Columbia
Frequently Asked Questions
What is Anteneh Tesfaye, MD's specialty? ▼
Anteneh Tesfaye, MD specializes in Hematology & Oncology Physician and practices in Washington, District of Columbia. Credentials: MD.
How much does Anteneh Tesfaye, MD prescribe under Medicare Part D? ▼
In 2023, Anteneh Tesfaye, MD wrote 366 Medicare Part D claims totaling $921K in drug costs for 72 beneficiaries.
Where is Anteneh Tesfaye, MD located? ▼
Anteneh Tesfaye, MD is located at 110 IRVING ST NW STE C2151, Washington, DC, 20010. Phone: (202) 877-6998.
What is Anteneh Tesfaye, MD's NPI number? ▼
Anteneh Tesfaye, MD's National Provider Identifier (NPI) is 1003128810, issued on 07/09/2010.
Does Anteneh Tesfaye, MD prescribe opioids? ▼
Yes, Anteneh Tesfaye, MD had 91 opioid claims in 2023 with an opioid prescribing rate of 24.9%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Anteneh Tesfaye, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Anteneh Tesfaye, MD's most frequently prescribed drugs include Oxycodone Hcl, Lenvima, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Anteneh Tesfaye, MD accept Medicare? ▼
Anteneh Tesfaye, MD appears in CMS Medicare data with 366 Part D claims and 72 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Anteneh Tesfaye, MD's credentials? ▼
Anteneh Tesfaye, MD's NPI is 1003128810 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.